* SATCOM demand is strong * There is good, untapped potential with Ovzon-3 * The stock trades at 13x...
Redeye returns with an update on Sprint Bioscience following recent events and the Q3 report.
Redeye is happy to see Systemair’s Q2 report beating expectations across the board.
Redeye comments on the negative phase II readout and changes its base case.
* Strong potential for margin improvements * Short term priorities presented * Favourable sales mix ...
XP Chemistries godkännande gällande användning av bolagets kapsaicin som fodertillsats för alla djur...
* CFO and new CEO gave a general presentation * Some positive market signs, mainly in public and tel...
Siili lowered its guidance for EBITA; the new guidance range mid-point stands c.
Redeye gives a short comment on the news that a bill has been passed in the US House of Representati...
Redeye provides a summary of Sdiptech’s CMD. The event presented slightly updated financial targets,...
Alligator Bioscience has secured additional subscription and top guarantee commitments for its SEK12...
Following Fiskars' profit warning on 19 November, we cut 2025E adjusted EBIT by 9%, while we make mo...
Redeye retains its positive take on Formpipe following the finalisation of the Public divestment and...
* Public divestment completed (EV SEK 850m)... * ..
Redeye provides an update following CI Games’ Q3 report, which demonstrated slightly softer-than-ant...
